Global Oseltamivir Market Growth 2025-2031

December 2025 | 82 pages | ID: G44711CD47E4EN
LP Information

Abstracts

The global Oseltamivir market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B (flu).

United States market for Oseltamivir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Oseltamivir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Oseltamivir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Oseltamivir players cover Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Oseltamivir Industry Forecast” looks at past sales and reviews total world Oseltamivir sales in 2024, providing a comprehensive analysis by region and market sector of projected Oseltamivir sales for 2025 through 2031. With Oseltamivir sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oseltamivir industry.

This Insight Report provides a comprehensive analysis of the global Oseltamivir landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oseltamivir portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oseltamivir market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oseltamivir and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oseltamivir.

This report presents a comprehensive overview, market shares, and growth opportunities of Oseltamivir market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Capsule
• Oral Solution

Segmentation by Application:

• Influenza A
• Influenza B

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Roche

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oseltamivir market?

What factors are driving Oseltamivir market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oseltamivir market opportunities vary by end market size?

How does Oseltamivir break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oseltamivir Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Oseltamivir by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Oseltamivir by Country/Region, 2020, 2024 & 2031
2.2 Oseltamivir Segment by Type
  2.2.1 Capsule
  2.2.2 Oral Solution
2.3 Oseltamivir Sales by Type
  2.3.1 Global Oseltamivir Sales Market Share by Type (2020-2025)
  2.3.2 Global Oseltamivir Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Oseltamivir Sale Price by Type (2020-2025)
2.4 Oseltamivir Segment by Application
  2.4.1 Influenza A
  2.4.2 Influenza B
2.5 Oseltamivir Sales by Application
  2.5.1 Global Oseltamivir Sale Market Share by Application (2020-2025)
  2.5.2 Global Oseltamivir Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Oseltamivir Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Oseltamivir Breakdown Data by Company
  3.1.1 Global Oseltamivir Annual Sales by Company (2020-2025)
  3.1.2 Global Oseltamivir Sales Market Share by Company (2020-2025)
3.2 Global Oseltamivir Annual Revenue by Company (2020-2025)
  3.2.1 Global Oseltamivir Revenue by Company (2020-2025)
  3.2.2 Global Oseltamivir Revenue Market Share by Company (2020-2025)
3.3 Global Oseltamivir Sale Price by Company
3.4 Key Manufacturers Oseltamivir Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Oseltamivir Product Location Distribution
  3.4.2 Players Oseltamivir Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR OSELTAMIVIR BY GEOGRAPHIC REGION

4.1 World Historic Oseltamivir Market Size by Geographic Region (2020-2025)
  4.1.1 Global Oseltamivir Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Oseltamivir Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oseltamivir Market Size by Country/Region (2020-2025)
  4.2.1 Global Oseltamivir Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Oseltamivir Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oseltamivir Sales Growth
4.4 APAC Oseltamivir Sales Growth
4.5 Europe Oseltamivir Sales Growth
4.6 Middle East & Africa Oseltamivir Sales Growth

5 AMERICAS

5.1 Americas Oseltamivir Sales by Country
  5.1.1 Americas Oseltamivir Sales by Country (2020-2025)
  5.1.2 Americas Oseltamivir Revenue by Country (2020-2025)
5.2 Americas Oseltamivir Sales by Type (2020-2025)
5.3 Americas Oseltamivir Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oseltamivir Sales by Region
  6.1.1 APAC Oseltamivir Sales by Region (2020-2025)
  6.1.2 APAC Oseltamivir Revenue by Region (2020-2025)
6.2 APAC Oseltamivir Sales by Type (2020-2025)
6.3 APAC Oseltamivir Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Oseltamivir by Country
  7.1.1 Europe Oseltamivir Sales by Country (2020-2025)
  7.1.2 Europe Oseltamivir Revenue by Country (2020-2025)
7.2 Europe Oseltamivir Sales by Type (2020-2025)
7.3 Europe Oseltamivir Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oseltamivir by Country
  8.1.1 Middle East & Africa Oseltamivir Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Oseltamivir Revenue by Country (2020-2025)
8.2 Middle East & Africa Oseltamivir Sales by Type (2020-2025)
8.3 Middle East & Africa Oseltamivir Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oseltamivir
10.3 Manufacturing Process Analysis of Oseltamivir
10.4 Industry Chain Structure of Oseltamivir

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Oseltamivir Distributors
11.3 Oseltamivir Customer

12 WORLD FORECAST REVIEW FOR OSELTAMIVIR BY GEOGRAPHIC REGION

12.1 Global Oseltamivir Market Size Forecast by Region
  12.1.1 Global Oseltamivir Forecast by Region (2026-2031)
  12.1.2 Global Oseltamivir Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oseltamivir Forecast by Type (2026-2031)
12.7 Global Oseltamivir Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Roche
  13.1.1 Roche Company Information
  13.1.2 Roche Oseltamivir Product Portfolios and Specifications
  13.1.3 Roche Oseltamivir Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Roche Main Business Overview
  13.1.5 Roche Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oseltamivir Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oseltamivir Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players of Oral Solution
Table 5. Global Oseltamivir Sales by Type (2020-2025) & (K Units)
Table 6. Global Oseltamivir Sales Market Share by Type (2020-2025)
Table 7. Global Oseltamivir Revenue by Type (2020-2025) & ($ million)
Table 8. Global Oseltamivir Revenue Market Share by Type (2020-2025)
Table 9. Global Oseltamivir Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Oseltamivir Sale by Application (2020-2025) & (K Units)
Table 11. Global Oseltamivir Sale Market Share by Application (2020-2025)
Table 12. Global Oseltamivir Revenue by Application (2020-2025) & ($ million)
Table 13. Global Oseltamivir Revenue Market Share by Application (2020-2025)
Table 14. Global Oseltamivir Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Oseltamivir Sales by Company (2020-2025) & (K Units)
Table 16. Global Oseltamivir Sales Market Share by Company (2020-2025)
Table 17. Global Oseltamivir Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Oseltamivir Revenue Market Share by Company (2020-2025)
Table 19. Global Oseltamivir Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Oseltamivir Producing Area Distribution and Sales Area
Table 21. Players Oseltamivir Products Offered
Table 22. Oseltamivir Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oseltamivir Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Oseltamivir Sales Market Share Geographic Region (2020-2025)
Table 27. Global Oseltamivir Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Oseltamivir Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Oseltamivir Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Oseltamivir Sales Market Share by Country/Region (2020-2025)
Table 31. Global Oseltamivir Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Oseltamivir Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Oseltamivir Sales by Country (2020-2025) & (K Units)
Table 34. Americas Oseltamivir Sales Market Share by Country (2020-2025)
Table 35. Americas Oseltamivir Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Oseltamivir Sales by Type (2020-2025) & (K Units)
Table 37. Americas Oseltamivir Sales by Application (2020-2025) & (K Units)
Table 38. APAC Oseltamivir Sales by Region (2020-2025) & (K Units)
Table 39. APAC Oseltamivir Sales Market Share by Region (2020-2025)
Table 40. APAC Oseltamivir Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Oseltamivir Sales by Type (2020-2025) & (K Units)
Table 42. APAC Oseltamivir Sales by Application (2020-2025) & (K Units)
Table 43. Europe Oseltamivir Sales by Country (2020-2025) & (K Units)
Table 44. Europe Oseltamivir Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Oseltamivir Sales by Type (2020-2025) & (K Units)
Table 46. Europe Oseltamivir Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Oseltamivir Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Oseltamivir Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Oseltamivir Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Oseltamivir Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Oseltamivir
Table 52. Key Market Challenges & Risks of Oseltamivir
Table 53. Key Industry Trends of Oseltamivir
Table 54. Oseltamivir Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oseltamivir Distributors List
Table 57. Oseltamivir Customer List
Table 58. Global Oseltamivir Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Oseltamivir Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Oseltamivir Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Oseltamivir Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Oseltamivir Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Oseltamivir Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Oseltamivir Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Oseltamivir Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Oseltamivir Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Oseltamivir Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Oseltamivir Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Oseltamivir Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Oseltamivir Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Oseltamivir Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Roche Basic Information, Oseltamivir Manufacturing Base, Sales Area and Its Competitors
Table 73. Roche Oseltamivir Product Portfolios and Specifications
Table 74. Roche Oseltamivir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Roche Main Business
Table 76. Roche Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Oseltamivir
Figure 2. Oseltamivir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oseltamivir Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Oseltamivir Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oseltamivir Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oseltamivir Sales Market Share by Country/Region (2024)
Figure 10. Oseltamivir Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Capsule
Figure 12. Product Picture of Oral Solution
Figure 13. Global Oseltamivir Sales Market Share by Type in 2025
Figure 14. Global Oseltamivir Revenue Market Share by Type (2020-2025)
Figure 15. Oseltamivir Consumed in Influenza A
Figure 16. Global Oseltamivir Market: Influenza A (2020-2025) & (K Units)
Figure 17. Oseltamivir Consumed in Influenza B
Figure 18. Global Oseltamivir Market: Influenza B (2020-2025) & (K Units)
Figure 19. Global Oseltamivir Sale Market Share by Application (2024)
Figure 20. Global Oseltamivir Revenue Market Share by Application in 2025
Figure 21. Oseltamivir Sales by Company in 2025 (K Units)
Figure 22. Global Oseltamivir Sales Market Share by Company in 2025
Figure 23. Oseltamivir Revenue by Company in 2025 ($ millions)
Figure 24. Global Oseltamivir Revenue Market Share by Company in 2025
Figure 25. Global Oseltamivir Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Oseltamivir Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Oseltamivir Sales 2020-2025 (K Units)
Figure 28. Americas Oseltamivir Revenue 2020-2025 ($ millions)
Figure 29. APAC Oseltamivir Sales 2020-2025 (K Units)
Figure 30. APAC Oseltamivir Revenue 2020-2025 ($ millions)
Figure 31. Europe Oseltamivir Sales 2020-2025 (K Units)
Figure 32. Europe Oseltamivir Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Oseltamivir Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Oseltamivir Revenue 2020-2025 ($ millions)
Figure 35. Americas Oseltamivir Sales Market Share by Country in 2025
Figure 36. Americas Oseltamivir Revenue Market Share by Country (2020-2025)
Figure 37. Americas Oseltamivir Sales Market Share by Type (2020-2025)
Figure 38. Americas Oseltamivir Sales Market Share by Application (2020-2025)
Figure 39. United States Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Oseltamivir Sales Market Share by Region in 2025
Figure 44. APAC Oseltamivir Revenue Market Share by Region (2020-2025)
Figure 45. APAC Oseltamivir Sales Market Share by Type (2020-2025)
Figure 46. APAC Oseltamivir Sales Market Share by Application (2020-2025)
Figure 47. China Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 51. India Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Oseltamivir Sales Market Share by Country in 2025
Figure 55. Europe Oseltamivir Revenue Market Share by Country (2020-2025)
Figure 56. Europe Oseltamivir Sales Market Share by Type (2020-2025)
Figure 57. Europe Oseltamivir Sales Market Share by Application (2020-2025)
Figure 58. Germany Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 59. France Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Oseltamivir Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Oseltamivir Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Oseltamivir Sales Market Share by Application (2020-2025)
Figure 66. Egypt Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Oseltamivir Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Oseltamivir in 2025
Figure 72. Manufacturing Process Analysis of Oseltamivir
Figure 73. Industry Chain Structure of Oseltamivir
Figure 74. Channels of Distribution
Figure 75. Global Oseltamivir Sales Market Forecast by Region (2026-2031)
Figure 76. Global Oseltamivir Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Oseltamivir Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Oseltamivir Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Oseltamivir Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Oseltamivir Revenue Market Share Forecast by Application (2026-2031)